HirnTumor-Forum

Autor Thema: Flor Essence Tee?  (Gelesen 26323 mal)

Offline Jo

  • Mitglied Forum
  • God Mitglied
  • *****
  • Beiträge: 570
    • Profil anzeigen
Flor Essence Tee?
« am: 20. Juni 2004, 22:06:13 »
Noch ein anderes Mittel, das zur Zeit viel Aufmerksamkeit bekommt ist Flor Essence Tee oder Indianer Tee. Soll wohl allgemein in der Krebsheilung Erfolge erzielen. Was habt ihr hier schon davon gehört. Trinkt schon jemand den Tee? Erfahrungen?

Ulrich

  • Gast
Re:Flor Essence Tee
« Antwort #1 am: 06. August 2004, 22:03:22 »
Jede(r) darf in unserem Land tun und lassen, was sie / er will. Jeder darf mit seinem Körper "experimentieren". Wenn dieser Tee jemals eine wirkliche "Heilwirkung" gehabt hat oder haben sollte, dann meiner Meinung nach höchstens auf der Basis "Placebo-Effekt". (Link zu Wiki, Stand August 2004)

Außer den Verkäufern des Tees glaubt wahrscheinlich keiner an die Wirksamkeit, jedenfalls habe ich bis jetzt keinen seriösen Wissenschaftler gefunden, der diesen Tee propagiert.

Hier ein Artikel über Flor-Essence Tee (Juni 2004) vom Memory Sloan-Kettering Cancer Centre

Zusammenfassung in einem Satz: Es gibt keine Studien für die behauptete Wirkung.


Titel: Essiac
Quelle: http://www.mskcc.org/mskcc/html/69215.cfm (Stand August 2004)

Zitat: CLINICAL SUMMARY
This product is composed of 4 botanicals: cut or dried burdock root, powdered sheep sorrel root, powdered slippery elm bark, and powdered rhubarb root (1) (2). The formula is consumed as a tea. Promoters claim that this product boosts the immune system, acts as a tonic, and treats cancer and HIV. To date, however, no data or published clinical trials show efficacy for any claims made. Possible adverse effects include nausea, vomiting, diarrhea, constipation, hypoglycemia, and renal and hepatic toxicity with chronic consumption (3). Case reports indicate that burdock root contaminated with belladonna have caused atropine-like toxicity. No drug interactions are documented except for a single case report of decreased clearance of chemotherapy possibly due to inhibition of hepatic metabolism (4). Additional research is required to establish whether Essiac is safe and effective for any of its proposed claims.
 
SCIENTIFIC NAME
Burdock root (Arctium lappa), sheep sorrel (Rumex acetosella), slippery elm bark (Ulmus fulva), turkish rhubarb root (Rheum palmatum)
 
BRAND NAME
Essiac®, Vitaltea®, Flor-Essence®
 
PURPORTED USES
*   Cancer treatment
*   Health maintenance
*   HIV and AIDS
*   Immunostimulation

 CONSTITUENTS
Sheep sorrel (Rumex acetosella):
Derived from the aerial parts of the plant. Sheep sorrel historically has been used to treat inflammation, scurvy, cancer, and diarrhea. The major constituents of sheep sorrel include anthraquinones, oxalates, and various vitamins including A, B-complex, C, D, E, and K. Consumption of large doses may result in diarrhea from the anthraquinone content and renal and liver damage from the oxalate content. There are no published trials evaluating the efficacy of sheep sorrel for any the proposed claims.
Slippery elm (Ulmus fulva):
Derived from the inner bark of the tree. Slippery elm has been used historically for gastrointestinal disorders, skin ulcers or abscesses, cancers, cough, fevers, and inflammation. The primary constituent, mucilage, is thought to account for the demulcent effects. To date, no human or animal studies have been performed to evaluate the efficacy of any of the proposed claims. Toxicity of slippery elm is low, based on chemical components. No adverse reactions or drug interactions are reported in the literature. Slippery elm appears to be safe for coughs and minor gastrointestinal complaints. However, it should not be used to treat severe conditions such as cancer or bronchitis.
Burdock (Arctium lappa):
Derived from the root or seeds of the plant. Historically, burdock has been used as a diuretic and to reduce blood sugar levels. It is claimed to treat anorexia, gout, cancer, and HIV, although no clinical studies are reported in the literature. Animal studies indicate possible hypoglycemic effect; therefore, a theoretical interaction exists with insulin and hypoglycemics. Several cases of burdock tea contaminated with belladonna alkaloids have been reported in Europe and United States. Product should be certified against contamination and labeled accordingly.
Rhubarb (Rheum palmatum):
Derived from the root of the plant. Rhubarb has been used for a variety of conditions including cancer, immunosuppression, constipation, diarrhea, gastrointestinal ulcers, and chronic renal failure. The anthraquinone and tannins are thought responsible for the laxative and constipating effects, respectively. There is limited human clinical data for any of the claims made. Animal data show antitumor effects in mice, but this has not been studied in humans. Adverse effects are primarily gastrointestinal. Chronic consumption can cause hypokalemia due to diarrhea, possible renal and hepatic damage from oxalates, and theoretical hypokalemia when combined with diuretics and altered response to digoxin.  

MECHANISM OF ACTION
The mechanism of action is not established. Rhubarb and sheep sorrel contain anthraquinones that stimulate secretion of mucosa and water, as well as stimulate peristalsis. Additional activities of anthraquinones isolated from rhubarb show stimulation of IL-1, IL-6, and TNF in vitro and tumor necrosis against sarcoma 37, breast cancer, and Ehrlich cell lines in mice. Burdock root can induce hypoglycemia in animal models. Tannin extract may induce macrophage response and the lignan and sesquiterpene extracts were shown to inhibit platelet activating factor (PAF) in vitro (1) (2).
 
CONTRAINDICATIONS
Theoretically, patients with renal or hepatic insufficiency should not consume this product.
 
ADVERSE REACTIONS
Reported: Nausea, vomiting, diarrhea, hypokalemia due to chronic diarrhea, contact dermatitis, and anaphylaxis
(3)
 
DRUG INTERACTIONS
Cytochrome p450: Case report – decreased clearance of an experimental chemotherapy in a single patient taking Essiac. May be due to inhibition of cytochrome p450 isoenzymes.
(4)
 
LITERATURE SUMMARY AND CRITIQUE
No clinical studies have been published evaluating the claims made for Essiac.
 

REFERENCES
(1) Tamayo C, et al. The chemistry and biological activity of herbs used in Flor-essence herbal tonic and Essiac. Phytotherapy Res 2000;14:1-14.
(2) Locock RA. Essiac. Can Pharm J 1997;130:18-19,51.
(3) Kaegi E. Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ 1998;158:897-902.
(4) Geyer C, et al. Dose-schedule optimization the hexacyclic camptothecin (CPT) analog dx-8951f: a phase I and pharmacokinetic study with escalation of both treatment duration and dose (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 1999;18.
 
Written:    10/01/2001
Updated:   06/24/2004

Ulrich

  • Gast
Re:Flor Essence Tee
« Antwort #2 am: 26. Februar 2008, 18:38:30 »
http://www.cancer.gov/cancertopics/pdq/cam/essiac/healthprofessional/allpages/print

Auf einen Satz möchte ich aufmerksam machen, nämlich

No controlled data are available from human studies to suggest that Essiac or Flor•Essence can be effective in the treatment of patients with cancer.

Das heißt etwa: Es gibt keine kontrollierten Daten aus Versuchen an / mit Menschen, die belegen / vorschlagen, dass Essiac oder Flor Essence nützlich / wirksam sein kann zur Behandlung von Menschen mit Krebs.

Ulrich

  • Gast
Re:Flor Essence Tee
« Antwort #3 am: 26. Februar 2008, 18:41:24 »
Quelle / Link: http://www.bccancer.bc.ca/HPI/UnconventionalTherapies/EssiacFlor%2aEssence.htm

Ich zitiere daraus und markiere die wichtigen Aussagen:

>Professional Evaluation/ Critique

"A 1982 study by the Canadian government of cancer patients taking Essiac found that patients did not benefit from it, and laboratory research conducted in 1983 by the U.S. National Cancer Institute found no merit to the product." (Cassileth)

"...360 patients with breast, prostate or GI cancer attending outpatient clinics at Princess Margaret were surveyed regarding their experiences with Essiac... Of patients on Essiac, 30% felt it had helped them. The benefit was described as psychological in 54%, physical in 29% and unspecified in the remainder." (Karn)

"Long term anthranoid laxative [eg. rhein and emodin found in essiac] use is correlated with increased risk of colon cancer." (Van Gorkom)

"The review of all the information about Essiac for the task force reveals some weak evidence of its effectiveness and suggests that Essiac is unlikely to cause serious side effects when used as directed. However, the nature and quality of studies reporting benefit are such that the findings can only be regarded as preliminary. High-quality and open-minded research into the effects of this popular unconventional therapy is needed. The principal danger of this and other unconventional therapies is that they may delay the diagnosis and conventional treatment of serious diseases." (Kaegi)

"Keith I. Block, M.D., director of Cancer Care at the Edgewater Medical Center in Chicago, is among those physicians who do not regard Essiac as particularly powerful against cancer. It is possible that Essiac is less effective today than it was decades ago. Certainly our diet and environment have become increasingly polluted since the early 1900's, and that places a growing burden on the body's immune and detoxification systems." (Diamond)

Dr. K.J.R. Wightman, medical director of the Ontario Cancer Treatment and Research Foundation and a former president of the Royal College of Physicians and Surgeons commented on the studies: "In the past three months there has been considerable emotion and concern regarding a herbal remedy for cancer (Essiac). During this period the preparation as supplied by Nurse Caisse from Bracebridge has been tested by a reputable investigator on patients with a variety of malignancies... there is no evidence of any alteration in the disease process of any of the patients. However subjective improvements in the sense of well being were noted in a number of the patients, although this could or could not be a placebo effect."

Caisse's story, which was published in Homemaker's Magazine (Toronto) in 1977 precipitated a great deal of public interest and resulted in scientific investigation.

In one trial, out of 40 patients, 18 have died and 15 have been withdrawn because of definite deterioration. Four who had initially very slowly progressive disease continue on the preparation but have shown no response. The remaining three patients with chronic lymphatic leukemia had no change in any parameter of their disease status. Data on a further 25 patients are being compiled by a separate investigator with similar results. "These unequivocal negative statistics refute any claims made as to the efficacy of this cancer cure with the material provided in the suggested dosage schedules." (Wightman)

The Health Protection Branch (Canada) contacted 150 physicians who were known to have received supplies of Essiac from Resperin Corporation in Toronto for individual patients. Replies from 74 of the physicians concerning 86 patients revealed that "47 patients reported no benefits; 8 of the reports were not evaluable; 17 patients had died; 1 patient was reported to have had a subjective improvement; 5 patients were reported as requiring less analgesia; 4 patients were said to have an objective response; and 4 patients were in a stable condition." In 1982, the 8 patients who had an objective response or who had remained stable were re-examined by their physicians and the following results were obtained:

"In 3 of the 8 the disease had progressed; 2 had died; and 3 were remaining stable. The 3 stable patients' histories were further documented and it is the impression of the Health Protection Branch that in these cases the stability was due to other forms of treatment. The conclusion from these 86 patients must therefore be that Essiac had not altered the progression of cancer in these patients, and did not show any specific benefit with the exception of a possible placebo effect in some cases." (Sproul)

In a later issue, Homemaker's Magazine printed the following retraction: "The two doctors who tested Essiac - Caisse's herbal tea which appeared to have merit in the treatment of cancer - have concluded that there is no evidence that the preparation cures cancer... they revealed that Essiac had been given to 60 cancer patients, and that the results were 'without evidence of any alteration in the disease process...'" (Hughes)

Prior to signing over the formula for Essiac to the Resperin Corporation, Caisse refused to share her secret remedy. At least eight offers to help her achieve recognition and distribution for Essiac were made. Some were from scientific groups, some from laymen. She rejected them all. (Fraser)

In 1936 Dr. Banting of the Banting Institute offered to provide Mrs. Caisse with mice inoculated with mouse sarcoma, provide her with chickens inoculated with Rouse sarcoma and "the animals will be placed at her disposal in the laboratory within the hours of 9-5." She was not asked to divulge any secrets concerning her treatment. This offer by the Banting Institute was turned down by Mrs. Caisse.

At some time in the 1950s, Dr. Shields Warren of the U.S. National Cancer Institute suggested they would do animal tests but this was rejected by Mrs. Caisse when it was found that the Cancer Institute would require the formula. (Boyes)

"Dr. D. Walde of Sault Ste. Marie, obtained some Essiac and tested it on 40 patients with proven cancer. In none of these patients was there any measurable improvement." (Boyes) (Walde)

"However, despite its long use as a folkloric remedy, no solid evidence exists that burdock exhibits any useful therapeutic activity." (Tyler)

"There are a number of herbal distributors who claim to sell the original Essiac. However, there are also disputes about whether certain brands are the real thing." (Ontario)"<

 



SMF 2.0.19 | SMF © 2022, Simple Machines
Hirntumor Forum © 1996-2022 hirntumor.de
Impressum | Datenschutzerklärung